Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese

Pharmacogenetics

Volumn 6, Issue 3, 1996, Pages 265-267

  Takakubo, Fumie ^a   Kuwano, Akira ^a   Kondo, Ikuko ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

(S) mephenytoin; CYP2C19m1 and CYP2C19m2; Poor metabolizer

Indexed keywords

CYTOCHROME P450 ISOENZYME; MEPHENYTOIN; RESTRICTION ENDONUCLEASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; DRUG METABOLISM; DRUG URINE LEVEL; ETHNIC GROUP; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFANT; INHERITANCE; JAPAN; NEWBORN; NORMAL HUMAN; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ARYL HYDROCARBON HYDROXYLASES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; JAPAN; MALE; MEPHENYTOIN; MIDDLE AGED; MIXED FUNCTION OXYGENASES; PEDIGREE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION;

EID: 0029994586     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199606000-00011     Document Type: Article

References (7)

1. de Morais SMF, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994a: 269, 15419-15422.
2. de Morais SMF, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994b: 46, 594-598.
3. Goldstein JA, Faletto MB, Romkes-Spatks M, Sullivaan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 1994: 33, 1743-1752.
4. Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 1985: 38, 402-408.
5. Ward SA, Goto F, Nakamura K, Jacqz E, Wilkinson GR, Branch RA. S-Mephenytoin 4′-hydroxylase is inherited as an autosomalrecessive trait in Japanese families. Clin Pharmacol Ther 1987: 42, 96-99.
6. Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther 1984: 36, 773-780.
7. Wilkinson GR, Guengerich FP, Branch RA. Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther 1989: 43, 53-76.